June 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


CDMRP Pre-Announcements for 2017
To be Announced See Links Below Federal Breast/Ovarian

CDMRP
Prostate Cancer Research Program (PCRP) &
Lung Cancer Research Program (LCRP)
FY17 Pre-announcements

Descriptions of the initiatives planned for these programs can be found at the links below.  The pre-announcements allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Contact: Office of Sponsored Research (x6804)
Program Links: Prostate Cancer Research Program
Lung Cancer Research Program


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


Updated
Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
W911NF-17-S-0002 01
April 2017 - 31 March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding. 
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W911NF-17-S-0002


NEW
Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1
Various NCI

Multiple See Below Federal Cancer Moonshot

Cancer Moonshot - Funding Opportunities

NCI has identified funding opportunity announcements (FOAs) from within its extensive research portfolio that address the goals of the Cancer Moonshot.   This portfolio will expand over the next 7 years.  Planning for implementation of longer-term scientific initiatives is underway.  Multiple ways to fund the best science, including grants, supplements and other mechanisms are being considered.
Due Dates: Multiple - See specific FOA
Amount & Project Period: See specific FOA
Eligibility: See specific FOA
Contact: Office of Sponsored Research (x6804)
Link: Cancer Moonshot Funding Opportunities


NEW
May 24 (LOI) HOPA Members Non-federal Hematology Oncology

The Hematology/Oncology Pharmacy Association (HOPA) Foundation
2017 HOPA Research Fund Award

To support a hematology/oncology pharmacy practice research project with subsequent publication.   Pharmacy practice is broadly defined including areas such as outcomes, surveys, patient safety, standards validation, and translational science applications. Multiple institutions may be involved in the project, and co-PI projects are allowed.
Due Dates: May 24 (Letter of Intent)
Invited Applications:  Sept. 05 (OSR) Ι Sept. 07 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Open to all HOPA members
Contact: Office of Sponsored Research (x6804)
Link: Research Grant Announcement
R21 NIH

May 30 (LOI) All Ranks Federal NCI Provocative Questions

Research Answers to NCI's Provocative Questions

The purpose is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative.  Each application must address one and only one specific PQ, exactly as defined in FOA.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 Due Date:  Oct. 30
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-018 
Companion RFA: RFA-CA-17-017 (R01)
U01 NCI
RFAs also listed below for R01, P01 and P50 awards
May 30 (LOI) All Ranks Federal NCI Provocative Questions

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions

This FOA invites revision applications from investigators with active NCI U01 research project awards. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-17-017 (R01) and RFA-CA-17-018 (R21) (See Above).  Research is encouraged that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care.
Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent U01 award. 
Due Dates: May 30 (Letter of Intent)
Applications Due: June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 Due Date:  Oct. 30
Amount & Project Period: Not to exceed $150,000/yr.(Direct Costs)
May request support for up to two years, not to exceed remaining number of years on parent grant. Parent grant must be active when application is submitted.
Eligibility: The PD/PI (or Contact PD/PI for multi-PD/PI awards) on the parent award must remain the same on the revision application.
If a no-cost extension is needed on the parent grant, it must be in place before the revision application is submitted.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-020
Companion RFAs: RFA-CA-17-019, Revision applications for R01 Research Project Grant
RFA-CA-17-021, Revision applications for P01 Research Program Projects
RFA-CA-17-022, revision applications for P50 Specialized Center
R01 NCI

May 30 (LOI) All Ranks Federal Imaging - CTs

Early Phase Clinical Trials in Imaging and Image-Guided Interventions

This FOA is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 & 2018 Due Dates: Oct. 11; and Feb. 14; June 28, & Oct. 11, 2018
Amount & Project Period: $500,000 (Direct Costs) for total period.  No more than $250,000 (Direct Costs) may be requested in any single year. - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-167

May 31 All Ranks Non-federal Ovarian

Tell Every Amazing Lady Louisa M. McGregor Ovarian Cancer Foundation
2017 T.E.A.L. Medical Research and Awareness Program Beneficiary

The Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation 2017 Medical Research Program offers funding in support of ovarian cancer research studies that are most aligned with that mission as determined by the T.E.A.L.® board of directors and scientific advisory board. The mission of the T.E.A.L.® is to promote public awareness of and education about the signs, symptoms, and risk factors of ovarian cancer, provide support to survivors, and raise funds for research in order to find a cure.
Due Dates: May 29 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: $60,000/year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP


May 31 Postdocs/Junior Faculty Non-federal Biomedical Science Prize

Vilcek Foundation
Prizes for Creative Promise in Biomedical Science

The Vilcek Foundation will award prizes to young foreign-born biomedical scientists who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.
Due Dates: May 31 (Sponsor)
Amount & Project Period: $50,000  Unrestricted Cash Prize
Eligibility: Must have been born outside the U.S. and be no more than 38 years old as of December 31, 2017.
Must be a naturalized citizen or permanent resident (green card holder) of the U.S.; hold an H1B or O-1 visa and have been living & working in the U.S. for at least 5 years; or have been granted Deferred Action for Childhood Arrivals (DACA) status. Must have earned a doctoral degree (M.D., Ph.D., or equiv.), intend to pursue a professional career in the U.S., and hold a full-time position at an academic institution or other organization.
Link: Overview/Online Application
S10 NIH

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
May 31 See Below Federal Equipment

Shared Instrumentation Grant (SIG) Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.
Due Dates: May 26 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: Maximum award is $600,000 - 1 year
Eligibility: PD/PI should have documented (in the biographical sketch) technical expertise directly related to the type of the chosen instrument. PD/PI does not need to have an NIH research grant or any other research support, but is expected to be an expert on the requested instrument. PD/PI may be a Core director, tenured, or non-tenured faculty member of the applicant organization.  Multiple PDs/PIs are not allowed.
Three Major Users (w/active NIH research awards) having a substantial need for the instrument must be identified. Once this eligibility requirement has been met, additional users with active research awards from NIH or other sources may be added as Major or Minor Users
Contact: Office of Sponsored Research (x6804)  
FOA Link: PAR-17-074

NEW
June 01 (LOI) All Ranks Federal PCOR

Patient Centered Outcomes Research Institute
Engagement Award: Knowledge, Training and Development, and Dissemination Awards

These awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise.
Due Dates: June 01 (Letter of Intent)
Full proposals are due 40 days after review and approval of the LOI
Amount & Project Period: $250,000 (Total Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Guidelines


June 01 Postdocs/Junior Faculty Federal Career Development

Air Force Office of Scientific Research
Fiscal Year 2018 Air Force Young Investigator Research Program (YIP)
Broad Agency Announcement (BAA) BAA-AFRL-AFOSR-2017-0002

This program intends support for scientists and engineers demonstrating exceptional ability and promise for conducting basic research. The program objective is to foster creative basic research in science and engineering and enhance early career development of outstanding young investigators.
Due Dates: May 30 (OSR) Ι June 01(Sponsor)
Amount & Project Period: $450,000 - 3 years
Eligibility: Received PhD or equiv. April 1, 2012 or later;
OR
Received PhD or equiv. bet.  April 1, 2010 & April 1, 2012, and presently hold a tenure-track faculty position <2 years before April 1, 2017.
Must be a U.S. citizen, national, or permanent resident.
Contact: Office of Sponsored Research (x6804)
Link: BAA-AFRL-AFOSR-2017-0002
Admin. Supplements NCI


June 01 See Below Federal See Below

National Cancer Institute Administrative Supplements

Due Dates: May 30 (OSR) Ι June 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)

Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts

NCI announces an opportunity for awardees holding eligible NCI-funded awards to request administrative supplement funding to support augmented efforts to refine automated methodologies to obtain more accurate and reliable lifetime residential history data and linkages that would enhance cancer research.
Amount & Project Period: Max. $125,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding.  Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; U01; UM1. Only one application per parent award is allowed.
FOA Link: PA-17-222
 

Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers

NCI invites applications for supplemental funding to eligible NCI awards so that involved personnel (awardees) can advance their efforts to gain needed knowledge on rare cancers. The goal is to support population-based, hypothesis-testing studies that will increase  understanding of the etiology or post-diagnosis outcomes of rare cancers.
Amount & Project Period: Max. $150,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding. 
Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; R03; R21; U01; UM1.
Only one application per parent award is allowed.
FOA Link: PA-17-223
 

Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies

Funds are available for administrative supplements to prepare and deposit individual-level data from cancer epidemiology studies into NCI-supported, controlled-access databases including the Cancer Epidemiology Data Repository (CEDR) and the database of Genotypes and Phenotypes (dbGaP).
Amount & Project Period: Max. $100,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding.  Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; R03; R21; U01; UM1.
Only one application per parent award is allowed.
FOA Link: PA-17-224
U01 NIH
NCI is a participating Institute
June 05 All Ranks Federal Health Behaviors

Intensive Longitudinal Analysis of Health Behaviors: Leveraging New Technologies to Understand Health Behaviors

 NCI is interested in supporting research in the following specific content areas:
     Projects that incorporate geospatial factors into data collection and analysis plans to account for data collection across diverse places.
     Incorporate data from multiple levels (e.g., biological, intrapersonal, interpersonal, community, policy) and types (e.g., self-report; sensor data) to explain and understand risky behaviors such as alcohol use, sedentary behavior, smoking, and poor diet.

Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Limited to $500,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-17-004
Companion RFA: RFA-OD-17-005, U24 

R01 NIH
NCI is a participating Institute
June 05 All Ranks Federal Human Microbiome & Cancer

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research

NCI encourages research on the microbiome and cancer, including the influence of pre/probiotics on functional and molecular profiles in cancer prevention, development and treatment.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-15-135
Companion FOA: PA-15-127 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)
R01 NIAAA
NCI is a participating Institute
June 05 All Ranks Federal Alcohol-associated Cancers

Mechanisms of Alcohol-associated Cancers

The purpose is to invite applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk.  Research seeking to elucidate the mechanisms by which components of tobacco products, including ENDS interact with alcohol consumption to affect carcinogenesis is of high interest to NCI.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-220
Companion FOA: PA-17-219, R21
R01 NCI

June 05 All Ranks Federal See Specific FOA

New and/or Re-Issued NCI Funding Opportunity Announcements

Below are a few R01 Funding Opportunity Announcements (FOAs) that have been renewed with new FOA numbers or newly published within in the last few months.   Please see Funding Opportunities by Type for a complete listing of NCI funding Opportunities.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Application Budgets not limited - 5 years (Note:  This may vary with some R01 announcements)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Title & Link: Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-17-110 (This one has a companion R21 FOA (PA-17-109)

Research Projects to Enhance Applicability of Mammalian Models for Translational Research PAR-17-245

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research PAR-17-244
U01 NCI

June 05 All Ranks Federal Epidemiology

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts

The purpose is to support of the core functions of Cancer Epidemiology Cohorts (CECs), as well as methodological research. This FOA is intended to support maintenance of existing CECs infrastructure and resource sharing with broader scientific communities.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: 1.25M/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-233
R01 NIH

June 07 All Ranks Federal In vivo Cancer Imaging Systems

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems

The purpose is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem.
Due Dates: Applications Due:  June 05 (OSR) June 07 (Sponsor)
Additional 2017 Due Date:  Oct. 03
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-093


NEW
June 08 (Pre-application) See Below Federal Breast

Breast Cancer Research Program (BCRP)

Due Dates: June 08 (Pre-application)
Full Applications Due:  June 13 (OSR) Ι June 15 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: BCRP Program Announcements Ι Pre-application Site
 

Breakthrough Fellowship
W81XWH-17-BCRP-Breakthrough_Fellowship

This award supports recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral fellowship and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research.
Amount & Project Period: $300,000 (Direct Costs) - 3 years
Eligibility: Must have been in laboratory or clinical research setting where proposed research is to be performed for no more than 2 years as a postdoc, and have a total of less than 4 years' experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training)
PA Link: W81XWH-17-BCRP-Breakthrough_Fellowship
 

Breakthrough Award Levels 1 & 2
W81XWH-17-BCRP-BREAKTHROUGH-FL12

May be small- to large-scale projects, at different stages of idea and research development. Two different funding levels, based on scope of research, are available. Funding Level 1 is for innovative, high-risk/high-reward research in earliest stages of idea development. Research with potential to yield new avenues of investigation.  Proof of concept. No preliminary data required. Funding Level 2 is for research already supported by preliminary data having potential to make significant advancements toward clinical translation.
Amount & Project Period: Level 1:  $375,000 - 3 years
Partnering Option:  $600,000 (Combined direct Costs)
Level 2:  $750,000 - 3 years
Partnering Option:  $1M (Combined direct Costs)
The Partnering PI Option is structured to accommodate two PIs referred to as the Initiating PI and the Partnering PI, each of whom will receive a separate award. (See FOA for details)
Eligibility: Investigators at all academic levels
PA Link: W81XWH-17-BCRP-BREAKTHROUGH-FL12
 

Era of Hope Scholar Award
W81XWH-17-BCRP-EOHS

This award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer.
Amount & Project Period: $2.5M (Direct Costs) - 4 years
Eligibility: Must be independent investigator w/in 6 years of the last training position as of application submission
PA Link: W81XWH-17-BCRP-EOHS


NEW
June 09 (Pre-application) See Below Federal Breast
Due Dates: June 09 (Pre-application)
Invited Applications:  Aug. 29 (OSR) Ι Aug. 31 (Sponsor)

Breakthrough Award Levels 3 & 4
W81XWH-17-BCRP-BREAKTHROUGH-FL34

Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Two different funding levels, based on the scope of the research, are available: Funding Level 3:  Advanced translational studies having potential for near-term clinical investigation. Small-scale clinical trials may apply. Funding Level 4: Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer.  Near-term clinical impact is expected. Human clinical testing is required. PIs are expected to have experience in successfully leading large-scale projects. (Note: An invited oral presentation is a requirement for application review of Funding Level 4 projects)
Amount & Project Period: Level 3:  $2.5M - 4 years
Partnering Option:  $4M (Combined direct Costs)
Level 4:  $10M - 3 years
Partnering Option:  Same funding limit
The Partnering PI Option is structured to accommodate two PIs referred to as the Initiating PI and the Partnering PI, each of whom will receive a separate award. (See FOA for details)
Eligibility: Investigators at all academic levels
Note: Each individual may submit only one Funding Level 3 pre-application and one Funding Level 4 pre-application as a PI or Initiating PI.
PA Link: W81XWH-17-BCRP-BREAKTHROUGH-FL34
 

Distinguished Investigator Award W81XWH-17-BCRP-DIA  

This award enables established visionary leaders from any field to pursue innovative ideas that could accelerate progress toward ending breast cancer. The central feature of the Distinguished Investigator Award is that the PI must propose research that is a fundamental shift from his/her track record of research and addresses one or more BCRP overarching challenge(s).
Amount & Project Period: $3M (Direct Costs) - 4 years
Eligibility: Must be at or above the level of Assistant Professor (or equivalent) and be more than 6 years beyond the last mentored position.
PA Link: W81XWH-17-BCRP-DIA
 

Innovator Award
W81XWH-17-BCRP-INNOV  

This award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer.
Amount & Project Period: $5M (Direct Costs) - 4 years
Eligibility: Must be at or above Associate Professor (or equiv.)
PA Link: W81XWH-17-BCRP-INNOV
R01 NIH
NCI is a participating Institute
June 11 (LOI) All Ranks Federal Sleep Disparities

Mechanisms and Consequences of Sleep Disparities in the U.S.

NCI is particularly interested in understanding the mechanisms underlying how sleep deficiency or sleep disruption among minority and health disparity cancer populations may contribute to the disparity of cancer therapeutic outcomes such as progression-free survival, or overall survival through effect on therapeutic efficacy and quality of life during cancer treatment.
Due Dates: June 11 (Letter of Intent)
Application Due: Jul. 07 (OSR) Ι Jul. 11 (Sponsor)
Additional Due Dates:  July 11, 2018 & July 11, 2019
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-234
Companion FOA: PAR-17-235 (R21)
R01 NCI

June 13 All Ranks Federal Cancer Communication

Innovative Approaches to Studying Cancer Communication in the New Media Environment

This FOA invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life.
Due Dates: June 09 (OSR) Ι June 13 (Sponsor)
Additional Due Date:  Oct. 11
Amount & Project Period: Application Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-249
Companion FOA: PAR-16-248 (R21)
U24 NCI

NEW
June 14 All Ranks Federal IT  & Cancer
Research Management

Advanced Development of Informatics Technologies for Cancer Research and Management

The purpose is to invite applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.
Due Dates: June 12 (OSR) Ι June 14 (Sponsor)
Amount & Project Period: Not to exceed $600,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-331
Companion FOAs: PAR-15-334, R21
PAR-15-332, U01
PAR-15-333, U24


NEW
June 14 (Pre-application) All Faculty Ranks Federal Ovarian

Ovarian Cancer Research Program (OCRP)
Pilot Award
W81XWH-17-OCRP-PA

This award supports exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models). Proposed research should include a testable hypothesis based on strong scientific rationale and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer.
Due Dates: June 14 (Pre-application)
Invited Applications: Aug. 22 (OSR) Ι Aug. 24 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Established Investigator Option: Independent Investigator more than 3 years since last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equiv.
Early-Career Investigator Option: At full application submission deadline, Investigator must be: w/in 3 years of last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent. Or
In a postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent.  An eligibility letter for the Early-Career Investigator option is required with the submission of both the pre-application and full application.
Contact: Office of Sponsored Research (x6804)
Links: Program Announcements (Primary Link)
W81XWH-17-OCRP-PA  Ι  Pre-application Site


NEW
June 15 (Optional LOI) All Ranks Non-federal Elderly Populations

The Retirement Research Foundation
Responsive Grants Program

Grants will be awarded to projects that provide direct services, advocacy, education, and/or training programs for professionals working with elders, as well as for research that investigates causes and solutions to significant problems of older adults.
Due Dates: June 15 (Optional Letter of Intent)
Applications Due:  Jul. 28 (OSR) Ι Aug. 01(Sponsor)
Amount & Project Period: $ not specified- generally 1-2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Responsive Grants
Admin. Supplement NCI

June 15 See Below Federal Immunotherapy

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy

The overarching goal is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grantee and a current NIAMS grantee, are encouraged to propose collaborative pilot projects that utilize their complementary and synergistic expertise.
Due Dates: June 13 (OSR) Ι June 15 (Sponsor)
Amount: Max. $200,000 (Direct Costs)/yr. ($100,000 per collaborating PD/PI/IC), regardless of the number of collaborating units.
Performance Period: Must be w/in currently approved project period for existing parent award.
Both collaborating PDs/PIs must have at least one full year of active funding (excluding no-cost extension periods) remaining at time of anticipated award for a one year APRC request and two years of active funding (excluding no-cost extension periods) remaining at time of anticipated award for a two year APRC request.
An anticipated award date of August 15, 2017 can be used for this calculation.
Eligibility: Must hold eligible parent award:
Only PDs/PIs with active NCI, NIAID, or NIAMS funding of the eligible grant mechanisms (See FOA), in the areas of cancer immunotherapy, peripheral mechanisms of immune tolerance, or autoimmunity are eligible;
PDs/PIs may belong to the same or different departments w/in an institution, or from different institutions.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-248


June 15 Junior Faculty Non-federal Neurobiology

Eppendorf & Science Prize for Neurobiology

This annual Prize is an international award honoring young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. The winner and finalists are selected by a committee of independent scientists, chaired by Science's Senior Editor, Dr. Peter Stern.
Due Dates: June 15 (Sponsor) Entry form and additional submission materials must be submitted electronically through the prize management system.
Amount & Project Period:

The winner receives:
     >Prize money of US $25,000
     >Publication in Science of an essay by the winner about  
       his/her research
     >Full support to attend the Prize Ceremony held in  
       conjunction with the Annual Meeting of the Society for
       Neuroscience in the USA
     >An invitation to visit Eppendorf in Hamburg, Germany
     >Up to three finalists are honored, too!

Eligibility: Entrant must be a neurobiologist w/advanced degree received in the last 10 years and not older than 35 years of age;
Entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology;
Entrant must have performed or directed work described in essay;
Research must have been performed during previous 3 years.
Link: Overview



June 16 All Ranks Federal Health IT

Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)

This FOA invites grant applications for funding to conduct exploratory and developmental research grants for projects in the early and conceptual stages of development that will contribute to the evidence base of how health information technology (IT) improves health care quality and outcomes.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $300,000 (TOTAL) - 2 years
Eligibility: All Ranks - Note:  Each PD/PI must devote a minimum of 20% annual full-time effort in each year of this project (i.e., at least 8 hours per week).
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-246
R01 NIH
NCI is a participating Institute

NEW
June 17  (LOI) All Ranks Federal Tobacco

Tobacco Regulatory Science

The purpose is to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.
Due Dates: June 17 (Letter of Intent)
Aug. 15 (OSR) Ι Aug. 17 (Sponsor)
Additional Due Dates:  Feb. 13, 2018, Jul. 17, 2018, Feb. 13, 2019
Amount & Project Period: Limited to $300,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-17-007
Companion RFAs: RFA-OD-17-009, R21
RFA-OD-17-008, R03


June 20 All Faculty Ranks Non-federal Women's Cancers

The Foundation for Women's Wellness
2017 Research Awards

These research awards target early funding for small, short-term studies that hold promise for improving medical knowledge in leading female cancers.  Applications should only be for studies that are exploring basic, clinical or epidemiological lines of inquiry.
Due Dates: June 16 (OSR) Ι June 20 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be an M.D. and/or Ph.D. with a faculty appointment (assistant professor, or higher)
Contact: Office of Sponsored Research (x6071)
Link: Research Awards


NEW
June 21 (Pre-application) See Below Federal Ovarian

Congressionally Directed Medical Research Programs
Ovarian Cancer Research Program (OCRP)

 
Due Dates: June 21 (Pre-application)
Invited Applications: Sept. 04 (OSR) Ι Sept. 06 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: Program Announcements Ι Pre-application Site
 

Ovarian Cancer Academy - Early-Career Investigator Award
W81XWH-17-OCRP-OCA  

This Program Announcement solicits Early-Career Investigators to join the existing Ovarian Cancer Academy. This award enables the Early-Career Investigator (PI on application) to pursue an ovarian cancer project that may be basic, translational, and/or clinical research, under the guidance of a Designated Mentor. The Designated Mentor is not required to be at the same institution as the Early-Career Investigator.
Amount & Project Period: $725,000 (Direct Costs) - 4 years
Eligibility: Must be w/in 3 years of last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equiv. as of full application submission deadline.
NOTE:  An eligibility letter is required w/submission of both pre-application and full application.
May be a research- or physician-scientist;
Must not have a concurrent Career Development-like award at time of award;
Must have an institutional commitment of approximately 50% protected time for ovarian cancer research and Academy activities including participation in monthly webinars;
Must commit no less than 25% effort for first 2 years.
PA Link: W81XWH-17-OCRP-OCA
 

Clinical Development Award
W81XWH-17-OCRP-IIRA

The goal of this award is to accelerate clinical introduction of medical products and technologies targeting ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required.
Amount & Project Period: $600,000 (Direct Costs) - 3 years
(Optional Early-Career Investigator: If requesting an optional nested Early-Career Investigator, an additional $200,000 is allowed to support this investigator.)
Eligibility: Must be at or above the level of Assistant Professor (or equiv.) Optional nested Early-Career Investigator:  Must be w/in 5 years of last postdoctoral research position, and can only be selected if a clinical trial is being proposed.
PA Link: W81XWH-17-OCRP-CDA
 

Investigator-Initiated Research Award
W81XWH-17-OCRP-IIRA

This award is intended to support high-impact research that has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.
Amount & Project Period: $450,000 (Direct Costs) - 3 years
Eligibility: Must be at or above the level of Assistant Professor (or equiv.)
PA Link: W81XWH-17-OCRP-IIRA




NEW
June 26 (LOI) All Ranks Non-federal Breast

National Comprehensive Cancer Network and Pfizer Independent Grants for Learning & Change (IGLC)
2017 Clinical Pathways in Breast Cancer

This new initiative solicits proposals using clinical pathways to address a quality improvement (QI) initiative along the continuum of care for breast cancer patients.  Letters of Intent are encouraged that describe concepts and ideas for developing, implementing and evaluating guidelines-based clinical pathways in breast cancer.
Due Dates: June 26 (Letter of Intent)
Invited Applications Due:  Sept. 21 (OSR) Ι Sept. 25 (Sponsor)
Amount & Project Period: Not Stated
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview | RFP | Pfizer, Inc. Grant Application System



NEW
June 27 (NOON) All Faculty Ranks Non-federal Immune Therapy

SU2C Catalyst Research Grants: Genentech-Supported

The SU2C Catalyst establishes a mechanism through which industry and academic scientists in the cancer community will conduct SU2C collaborative research projects that will deliver significant benefits for patients and society, accelerating the development of new treatments and, where appropriate, combination therapies.  It takes a structured and prioritized approach to early-phase clinical studies and translational research in order to accelerate the time to get new treatments to patients.  As the Scientific Partner in the SU2C Catalyst, the American Association for Cancer Research (AACR) provides scientific oversight and conducts expert peer review and grants administration for SU2C. 
Due Dates: June 23 (OSR) Ι June 27 (Sponsor)
Amount & Project Period: $ 3,000,000.00 - 3 years
Eligibility: All Faculty Ranks - Multi-investigator, multi-institutional projects are required.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι proposalCENTRAL


NEW
June 28 (Pre-application) See Below Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)

Due Dates: June 28 (Pre-application)
Invited Applications Due:  Sept. 25 (OSR) Ι Sept. 27 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Program Announcements Ι Pre-application Site

Idea Development Award
W81XWH-17-LCRP-IDA

This mechanism promotes new ideas still in early stages of development and having potential to yield impactful data and new avenues of investigation. It supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
Amount & Project Period: $350,000 (Direct Costs) - 2 years
Eligibility: Investigators may be eligible for both New Investigator and Established Investigator categories, and choice of application category is at the PI's discretion, but only 1 application is allowed.  
Established Investigator:
Must be an independent investigator at or above the level of Assistant Professor (or equiv.);
New Investigator: By application due date, must have:
Not previously received an LCRP Idea Development Award or LCRP Early Investigator Synergistic Idea Award; and
Must be an independent investigator at or above Asst. Professor (or equiv) and w/in10 years of first faculty appointment (or equiv.) by due date.
PA Link: W81XWH-17-LCRP-IDA
 

Investigator-Initiated Translational Research Award
W81XWH-17-LCRP-IITRA

This mechanism supports translational research that will develop promising ideas in lung cancer into clinical applications. Research plan must involve a reciprocal flow of ideas and information between basic and clinical science, such as studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts; late-stage preclinical work leading to/preparing for a clinical trial; or correlative studies associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: All Ranks
PA Link: W81XWH-17-LCRP-IITRA
 

Translational Research Partnership Award
W81XWH-17-LCRP-TRPA

This mechanism supports partnerships between clinicians and research scientists that will accelerate movement of promising ideas in lung cancer into clinical applications. The intention is to fund a broad range of translational studies, including: studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts; late-stage preclinical work leading to/preparing for a clinical trial;  Pilot, proof-of-principle clinical trials (must include documentation of an existing IND or Investigational Device Exemption (IDE), if applicable); or correlative studies associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.
Amount & Project Period: $900,000 (Direct Costs) - 3 years
Eligibility: All Ranks - One partner in the collaboration must be a research scientist and the other must be a clinician.
PA Link: W81XWH-17-LCRP-TRPA


June 30 All Ranks Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants will be made for the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: June 28 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application
Lung Cancer Research
Foundation

NEW
July 01 All Ranks Non-federal Lung

Lung Cancer Research Foundation
Grant Program

This program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer.
Due Dates: June 29 (OSR) Ι Jul. 01 (Sponsor)
Amount & Project Period: $150,000 - 2 years
Eligibility: Individuals must fall into one of the following categories: Students and fellows Young and mid-career investigators with less than ten years' experience since initial faculty appointment Non-tenure track researchers, staff scientists, and clinicians. Senior investigators with more than ten years' experience since faculty appointment are not eligible for LCRF funding but are encouraged to mentor a junior team member through the application process.
Contact: Office of Sponsored Research (x6804)
Link: Guidelines




NEW
July 01 ALL Ranks (see below) Non-federal Clinical Oncology

SWOG Early Exploration and Development (SEED) Fund

This fund encourages preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).   Awards may assist investigators with projects supporting the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: June 29 (OSR) Ι Jul. 01(5:00, pm ET) (Sponsor)
Additional Due Date:  Dec. 01, 2017
Amount & Project Period: $50,000 (Direct Costs) - 1 to 2 years
Eligibility: Any SWOG investigator eligible for NIH funding
Contact: Office of Sponsored Research (x6804)
RFA Link: Overview Ι 2017 RFA


July 01 Postdocs Non-federal Career Development

The Helen Hay Whitney Foundation
2017 Research Fellowship

This fellowship supports early postdoctoral research training in all basic biomedical sciences.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr. 01:  $52,000 (Stipend) + $1,500 (Allowance)
Yr. 02:  $54,000 (Stipend) + $1,500 (Allowance)
Yr. 03:  $57,000 (Stipend) + $1,500  (Allowance)
Eligibility: Must have obtained or be in final stages of obtaining a Ph.D., M.D., or equiv.
Must not have more than 1 year of postdoctoral research experience at deadline for submitting application and who have received a PhD (or D.Phil. or equiv.) no more than 2 years before the deadline, or M.D. degree no more than 3  years before the deadline.
No more than one application from a laboratory during each annual cycle.  Applications from different laboratories/supervisors at the same institution are allowed.
Contact: Office of Sponsored Research (X6804)
Link: Research Fellowships

July 03 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)

Submission of well-conceived research projects that stimulate advancement of the practice of dermatologic surgery, the invention of new technologies or research projects that document the outstanding and high volume work of dermatologic surgeons are encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in Core surgical procedures and techniques; Cutaneous oncology; and new technologies.
Due Dates: June 29 (OSR) Ι Jul. 03(Sponsor)
Amount & Project Period: $20,000  
Eligibility: All Ranks - PD/PI must be ASDS member
Contact: Office of Sponsored Research, x6804
Link: Overview Ι Application Site
R25 NIH
NCI is a participating Institute
July 04 (LOI) All Ranks Federal BD2K Educ. resources

BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science

This FOA will support creative educational activities with a primary focus on Courses for Skills Development for biomedical researchers who need the requisite knowledge and skills to extract knowledge from biomedical Big Data.
Due Dates: Jul. 4 (Letter of Intent)
Applications Due:  Jul. 31 (OSR) Ι Aug. 02 (Sponsor)
Amount & Project Period: Not to exceed $200,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-HG-16-016
Companion RFAs: RFA-ES-16-002,  BD2K Mentored Career Development Award in
                             Biomedical Big Data Science for Clinicians
                             and Doctorally Prepared Scientists (K01)
RFA-ES-16-003,  BD2K Career Transition Award in Biomedical
                             Data Science for Intramural Investigators
                             (K22)
RFA-LM-16-002, Predoctoral Training in Biomedical Big Data
                             Science (T32)

July 06 Faculty Ranks Non-federal Career Development

Damon Runyon Cancer Research Foundation
Innovation Award

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances.
Due Dates: Jul. 03 (OSR) Ι Jul. 06 (Sponsor)
Amount & Project Period: $300,000 - 2 years (Stage 1 award will be for two years;  Stage 2 support for years 3 & 4 will be granted to those awardees who demonstrate progress on the proposed research during years 1 & 2 of the award.) 
Eligibility: Applicants must belong to one of the following categories: Tenure-track Assistant Professors w/in first four years of obtaining initial Assistant Professor position. (Cut-off date: July 1, 2013);
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before taking a tenure-track faculty position, and must have dedicated laboratory space and support of institution;
Not eligible are Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows; 
Applicants are expected to commit at least 80% of their full time effort to conducting research.
See award overview for additional eligibility details.
Contact: Office of Sponsored Research (x6804)
Links: Application Guidelines


NEW
July 13 (Pre-application) All Faculty Ranks federal Bone Marrow Failure

Congressionally Directed Medical Research Programs (CDMRP)
Bone Marrow Failure Research Program (BMFRP)
Idea Development Award
W81XWH-17-BMFRP-IDA

This award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP vision of understanding and curing BMF diseases. This mechanism supports new ideas w/a high probability of revealing new avenues of investigation, and should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.
Due Dates: July 13 (Pre-application) Pre-application Site
Invited Applications Due:  Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Amount & Project Period: $315,000 (Direct Costs) - 2 years
Eligibility: Established Investigators: Independent investigators at or above Asst. Professor (or equiv.) and 10 years or more from a terminal degree;
Early Career Investigators: Independent investigators at Assistant Professor, Instructor, or Assistant Research Professor (or equiv.) level and less than 10 years from terminal degree (excl. time spent in medical residency or during family medical leave) at time of application submission deadline Time spent as a postdoctoral fellow is not excluded and must be w/in 10-year span from the time of terminal degree.
Contact: Office of Sponsored Research (x6804)
Links: Program Announcements  Ι W81XWH-17-BMFRP-IDA
U01 NCI

July 14 All Ranks Federal Solid Tumor Therapies

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

The purpose is to invite applications proposing studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. Studies should generate validated high-quality preclinical data on the effects of molecular therapeutics when added to standard-of-care therapies for solid tumors. The specific purpose is to provide a more rational basis for prioritizing those NCI-supported investigational new drugs or agents (INDs) most likely to have clinical activity with chemo-radiotherapy.
Due Dates: Jul. 12 (OSR) Ι Jul. 14(Sponsor)
Additional Due Date:  Nov. 14, 2017
Amount & Project Period: Max. $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111




NEW
July 15 Postdocs Non-federal See Below

Science and Scilife Lab Prize for Young Scientists

Recent doctoral graduates in the life sciences may submit a 1000-word essay based on their thesis work.  The categories are Cell and Molecular Biology; Genomics and Proteomics; Translational Medicine; and Ecology and Environment
Due Dates: July 15
Amount & Project Period: The winners will:
>Be published by Science
> Receive up to 30,000 USD in prize money
> Be honored in Stockholm, Sweden during Nobel week
Eligibility: Postdocs - Must have been awarded Ph.D. between January 1 2015 and December 31 2016 Prizes will only recognize work that was performed while entrant was a graduate student.
Contact: SciLifeLabPrize@aaas.org
Link: Overview/Guidelines/Contact Information
R01 NCI

July 18 (LOI) All Ranks Federal Inter-organelle Communication

Inter-organelle Communication in Cancer

The purpose of this FOA is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.
Due Dates: Jul. 18 (Letter of Intent)
Applications Due:  Aug. 14 (OSR) Ι Aug. 16 (Sponsor)
Amount & Project Period: Application budgets not limited - 5  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-203
Companion FOA: PAR-17-204 (R21)


NEW
July 27 (LOI) All Ranks Federal Lung

Lung Cancer Research Program (LCRP)
Concept Award
W81XWH-17-LCRP-CA

This mechanism supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.  Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation.
Due Dates: Jul. 27 (Letter of Intent)
Applications Due:  Aug. 08 (OSR) Ι Aug 10 (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Primary Link Ι W81XWH-17-LCRP-CA Ι Pre-application Site


NEW
August 05 All Ranks Non-federal Mesothelioma

The Meso Foundation
Mesothelioma Research Funding

Eligible projects may relate to benchwork, translational or clinical research not presently funded.  Encouraged projects include: Strategies for early detection and prevention of mesothelioma; Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment taking advantage of these targets; Determination of clinical/molecular determinants for prognosis; and Therapeutic intervention, including: immune response targeted therapy; novel chemotherapeutic compounds; and novel radiation or surgical techniques.
Due Dates: Aug. 03 (OSR) Ι Aug. 05 (Sponsor
Amount & Project Period: $100,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview | proposalCENTRAL


Cycle II
August 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Fellowship Award

All theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention are encouraged for this fellowship.
Due Dates: Aug. 12 (OSR) Ι Aug. 15 (Sponsor)
Completed applications and USB flash drives must be in sponsor's office by 4:00 pm (ET) on the deadline - NOT postmarked by the due date.
Amount & Project Period: Funding is comprised of a progressive stipend starting at $52,000 and Expense Allowance ($2,000). -  4 years
Note:  Physician-scientists who have completed their residencies and clinical training and are board eligible in the United States will receive Level 2 funding
Eligibility: For degrees conferred between October 15, 2016 and August 15, 2017.
Contact: Office of Sponsored Research (x6071)
Links: Overview Ι Application Guidelines
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org